Patent · US Active

Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro

US11359201B2 · kind B2 · utility

1Cited by
23References
7Claims
0Family size

Inventor

Key dates

Filing dateAug 27, 2019
Grant dateJun 14, 2022
Priority date—
Expiry dateAug 27, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/51
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for down modulating target gene expression are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.